Kant, Shashi
- Brigham and Women's Hospital · Internal Medicine (investigator's affiliation)
- University of Texas Hlth Ctr at Tyler (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #25,075
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$479.3K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#25,075
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kant, Shashi as a PI. Multi-PI records show the full award amount for context.
- 5R01HD099756-05R01Contact PIPK/PD Optimized Cephalosporins Based Treatment Regimens for Children With MDR-TB$306.2Kaward amount
- 1R03TR004452-01R03Contact PIMixed Lineage Kinase 2 (MLK2) and vascular homeostasisBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$173.1Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Kant, Shashi as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardUniversity of Texas Hlth Ctr at Tyler
- 2020$500K Cumulative Funding
- 2020Multi-Institutional ResearchAwards at 2 institutions
- 2020R01 Grant Holder
- 2021$1M Cumulative Funding